A Study to Describe the Diagnosis, Anti-Cancer Treatment and Clinical Outcome in Patients With Newly Diagnosed Breast Cancer in Latin America

NCT04158258 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

2907

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Bevacizumab
DRUG: Trastuzumab
DRUG: Ado-trastuzumab emtamsine
DRUG: Pertuzumab
DRUG: Atezolizumab
DRUG: Capecitabine

Sponsor

Hoffmann-La Roche

Collaborators

[object Object]